Posts

Accenture Recognized as a Leader and Positioned Highest in Everest Group's PEAK Matrix Report for Data and Analytics Service Providers

NEW YORK; Oct. 31, 2019 – Accenture (NYSE: ACN) is acknowledged as a Leader in the Everest Group “PEAK Matrix™ for Data and Analytics Service Providers 2019” report. Accenture was positioned highest  in both the Market Impact and Vision & Capability categories.

Accenture Recognized as a Leader and Positioned Highest in Everest Group's PEAK Matrix Report for Data and Analytics Service Providers

NEW YORK; Oct. 31, 2019 – Accenture (NYSE: ACN) is acknowledged as a Leader in the Everest Group “PEAK Matrix™ for Data and Analytics Service Providers 2019” report. Accenture was positioned highest  in both the Market Impact and Vision & Capability categories. from News | Accenture Newsroom https://ift.tt/2Ntyj1q

Community College Students Can Help Offset the Nation's Tech Talent Shortage, Accenture Study Finds

NEW YORK; Oct. 31, 2019 – Community college students — with support from employers — are a key source of talent to help solve the country’s skilled tech talent shortage, according to results of a survey “Apprenticeships: From Community College to Promising Tech Career,” released today by Accenture (NYSE: ACN). from News | Accenture Newsroom https://ift.tt/2PBABOr

Accenture Interactive Acquires U.K. Digital Ventures Consultancy Bow & Arrow

LONDON; Oct. 31, 2019 – Accenture (NYSE: ACN) has acquired  Bow & Arrow , a U.K.- based digital ventures consultancy that helps clients identify and create new digital products and services that fulfil unmet customer needs. Financial terms were not disclosed. from News | Accenture Newsroom https://ift.tt/2JBZSnQ

Accenture to Help Santen Pharmaceutical Build a Global Intelligent Enterprise Platform on SAP® S/4HANA® to Drive Its Digital Transformation

TOKYO; Oct. 30, 2019 – Accenture (NYSE: ACN) has been selected to help Santen Pharmaceutical Co., Ltd. (Santen), an ophthalmic pharmaceutical company headquartered in Japan, build a global intelligent enterprise platform that will drive the company’s digital transformation.

Accenture to Help Santen Pharmaceutical Build a Global Intelligent Enterprise Platform on SAP® S/4HANA® to Drive Its Digital Transformation

TOKYO; Oct. 30, 2019 – Accenture (NYSE: ACN) has been selected to help Santen Pharmaceutical Co., Ltd. (Santen), an ophthalmic pharmaceutical company headquartered in Japan, build a global intelligent enterprise platform that will drive the company’s digital transformation. from News | Accenture Newsroom https://ift.tt/2Nq3Z7Q

Abu Dhabi firm to pick up minority stake in Rahul Munjal’s Hero Future Energy

Abu Dhabi firm to pick up minority stake in Rahul Munjal’s Hero Future Energy Abu Dhabi firm to pick up minority stake in Rahul Munjal’s Hero Future Energy The post Abu Dhabi firm to pick up minority stake in Rahul Munjal’s Hero Future Energy appeared first on Oil & Gas 360 . from Oil & Gas 360 https://ift.tt/31Zp8uP